OBJECTIVE: To assess the risk of ischaemic stroke associated with total serum homocyst(e)ine (tHcy) concentration. DESIGN: Cohort study. SETTING: Caerphilly, South Wales PARTICIPANTS: 2254 men age 50 to 64 years recruited between 1984 and 1988. RESULTS: 107 men developed ischaemic stroke and mean follow up time was 10.2 years. There was no significant difference in mean serum total homocyst(e)ine levels between stroke cases (12.2 micromol 95% CI 11.6 to 13.1) and non-cases (11.7 micromol 95% CI 11.5 to 11.9) (p=0.14). There was no significant risk for a standard deviation increase in homocyst(e)ine (adjusted hazard ratio = 1.1, 95% CI 0.9 to 1.4). An interaction was observed between homocyst(e)ine and age at entry (p=0.003). The adjusted odds ratio comparing the top quintile of homocyst(e)ine with the rest was 2.5 (95% CI 1.0 to 6.2) for strokes occurring under 65 years and 0.5 (95% CI 0.2 to 1.3) at 65 years or older (p value for interaction =0.02). Risk also differed by blood pressure status. The adjusted hazard ratio for a standard deviation increase in homocyst(e)ine was 0.8, (95% CI 0.6 to 1.2) for normotensive men and 1.3 (95% CI 1.1 to 1.7) for hypertensive men (p value for interaction =0.01). CONCLUSIONS: Overall, there is no significant relation between homocyst(e)ine and ischaemic stroke in this cohort. However, its aetiological importance may be greater for premature ischaemic strokes (<65 years) and in hypertensive men.
OBJECTIVE: To assess the risk of ischaemic stroke associated with total serum homocyst(e)ine (tHcy) concentration. DESIGN: Cohort study. SETTING: Caerphilly, South Wales PARTICIPANTS: 2254 men age 50 to 64 years recruited between 1984 and 1988. RESULTS: 107 men developed ischaemic stroke and mean follow up time was 10.2 years. There was no significant difference in mean serum total homocyst(e)ine levels between stroke cases (12.2 micromol 95% CI 11.6 to 13.1) and non-cases (11.7 micromol 95% CI 11.5 to 11.9) (p=0.14). There was no significant risk for a standard deviation increase in homocyst(e)ine (adjusted hazard ratio = 1.1, 95% CI 0.9 to 1.4). An interaction was observed between homocyst(e)ine and age at entry (p=0.003). The adjusted odds ratio comparing the top quintile of homocyst(e)ine with the rest was 2.5 (95% CI 1.0 to 6.2) for strokes occurring under 65 years and 0.5 (95% CI 0.2 to 1.3) at 65 years or older (p value for interaction =0.02). Risk also differed by blood pressure status. The adjusted hazard ratio for a standard deviation increase in homocyst(e)ine was 0.8, (95% CI 0.6 to 1.2) for normotensive men and 1.3 (95% CI 1.1 to 1.7) for hypertensivemen (p value for interaction =0.01). CONCLUSIONS: Overall, there is no significant relation between homocyst(e)ine and ischaemic stroke in this cohort. However, its aetiological importance may be greater for premature ischaemic strokes (<65 years) and in hypertensivemen.
Authors: P H Whincup; H Refsum; I J Perry; R Morris; M Walker; L Lennon; A Thomson; P M Ueland; S B Ebrahim Journal: Heart Date: 1999-10 Impact factor: 5.994
Authors: A G Bostom; H Silbershatz; I H Rosenberg; J Selhub; R B D'Agostino; P A Wolf; P F Jacques; P W Wilson Journal: Arch Intern Med Date: 1999-05-24
Authors: A G Bostom; I H Rosenberg; H Silbershatz; P F Jacques; J Selhub; R B D'Agostino; P W Wilson; P A Wolf Journal: Ann Intern Med Date: 1999-09-07 Impact factor: 25.391
Authors: A R Folsom; F J Nieto; P G McGovern; M Y Tsai; M R Malinow; J H Eckfeldt; D L Hess; C E Davis Journal: Circulation Date: 1998-07-21 Impact factor: 29.690
Authors: Richard M Martin; Yoav Ben-Shlomo; David Gunnell; Peter Elwood; John W G Yarnell; George Davey Smith Journal: J Epidemiol Community Health Date: 2005-02 Impact factor: 3.710